Stock Market News

Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment

Feb 20, 2025 - 18:21
 0
Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment
Read More

Tags:

Previous Article

Eramet eyes lithium tech opportunities amid Chinese export curbs

Next Article

Repsol cuts green hydrogen target by as much as 63%

Related Posts

Musk's xAI outperforms rivals with Grok-3 chatbot update

Musk's xAI outperforms rivals with Grok-3 chatbot update

Feb 18, 2025  0

Mexico airport operator GAP to invest $2.5 billion through 2029

Mexico airport operator GAP to invest $2.5 billion thro...

Feb 12, 2025  0

Putin says Russia should speed up lithium mining plans

Putin says Russia should speed up lithium mining plans

Feb 21, 2025  0